Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | MGAM | O43451 | 1/20 | 0.56 |
| ▸ | SI | P14410 | 1/20 | 0.56 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.56 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloroform SCHEMBL11511595 | 0.94 | GAA (0.50) | GAAMGAMSIMGAM2CYP4F2 | |
| SCHEMBL30800905 | 0.93 | GAA (0.65) | GAAMGAMSIMGAM2CYP4F2 | |
| SCHEMBL6403 | 0.93 | — | — | |
| Ethyl Acetate SCHEMBL2500756 | 0.92 | ALDH1A1 (0.56) | GAAMGAMSIMGAM2CYP4F2 | |
| Hexane SCHEMBL16566680 | 0.92 | DGKA (0.48) | GAAMGAMSIMGAM2CYP4F2 | |
| SCHEMBL16698948 | 0.90 | — | — | |
| Water SCHEMBL2542900 | 0.90 | GAA (0.62) | GAAMGAMSIMGAM2CYP4F2 | |
| Hydrochloric Acid SCHEMBL2655390 | 0.90 | — | — | |
| Alcohol SCHEMBL9306984 | 0.90 | GAA (0.62) | GAAMGAMSIMGAM2CYP4F2 | |
| Water SCHEMBL555135 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 926 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986310-A | Novel compound, namely rubusoside B, and preparation method and application thereof | 湖南中医药大学 | 2024-05-07 | — | — | CN | claimed |
| CN-115650913-B | Quinone quinoline compound and preparation method and application thereof | 北京中医药大学 | 2024-03-01 | — | — | CN | claimed |
| CN-115350177-B | Uric acid reducing function of extract and preparation method thereof | 暨南大学 | 2023-06-06 | — | — | CN | claimed |
| CN-112538016-B | Method for extracting chlorogenic acid n-butyl ester from peach blossom | 黄河科技学院 | 2023-03-10 | — | — | CN | claimed |
| CN-113461747-B | 2 compounds with hypoglycemic activity in rose hip | 吉林化工学院 | 2023-02-03 | — | — | CN | claimed |
| CN-115650913-A | Quinoid quinoline compound and preparation method and application thereof | 北京中医药大学 | 2023-01-31 | — | — | CN | claimed |
| CN-115518096-A | Integrated comprehensive extraction and separation method for effective components of epimedium | 李玉山 | 2022-12-27 | — | — | CN | claimed |
| CN-115350177-A | Uric acid reducing function of extract and preparation method thereof | 暨南大学 | 2022-11-18 | — | — | CN | claimed |
| CN-115015418-A | Quality detection method for Japanese ardisia herb decoction | 湖南新汇制药股份有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-113773361-A | Compound for treating hyperuricemia, composition thereof, preparation method and medical application | 深圳弘汇生物医药有限公司 | 2021-12-10 | — | — | CN | claimed |
| CN-112538016-A | Method for extracting chlorogenic acid n-butyl ester from peach blossom | 黄河科技学院 | 2021-03-23 | — | — | CN | claimed |
| CN-111172202-A | Phellinus strain of phellinus, and product, extract and application thereof | 财团法人食品工业发展研究所 | 2020-05-19 | — | — | CN | claimed |
| CN-107556358-B | Effective component of procoagulant cordyceps militaris and extraction and separation method and application thereof | 黄河科技学院 | 2019-08-23 | — | — | CN | claimed |
| US-10099998-B2 | Compound, and separation method, synthesis method and use thereof | BEIJING PEKING UNIVERSITY WBL BIOTECH CO., LTD. (CN) | 2018-10-16 | — | — | US | claimed |
| US-20180022688-A1 | COMPOUND, AND SEPARATION METHOD, SYNTHESIS METHOD AND USE THEREOF | BEIJING PEKING UNIVERSITY WBL BIOTECH CO., LTD. (CN) | 2018-01-25 | — | — | US | claimed |
| CN-107207404-A | Compound, its separation method, synthetic method and purposes | 北京北大维信生物科技有限公司 | 2017-09-26 | — | — | CN | claimed |
| CN-105732613-B | A kind of synthetic method of 9 demethyl (+) α dihydrotetrabenazineins | 江苏省原子医学研究所 | 2017-08-15 | — | — | CN | claimed |
| CN-105732613-A | Synthesis method of 9-demethyl-(+)-alpha-dihydrotetrabenazine | 江苏省原子医学研究所 | 2016-07-06 | — | — | CN | claimed |
| CN-101057895-B | 'Fuyanshu' preparation for treating gynopathy and its quality controlling method | BEIJING QIYUAN YIDE INST OF MATERIA MEDICA | 2010-05-19 | — | — | CN | claimed |
| CN-101057895-A | 'Fuyanshu' preparation for treating gynopathy and its preparation method and quality controlling method and application | QIYUANYIDE MEDICINES INST BEIJ (CN) | 2007-10-24 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180022688-A1 | COMPOUND, AND SEPARATION METHOD, SYNTHESIS METHOD AND USE THEREOF | HMGCR, COASY, DHCR7 | GAA 452/4885MGAM 629/4885SI 219/4885 |
| US-10099998-B2 | Compound, and separation method, synthesis method and use thereof | HMGCR, COASY, DHCR7 | GAA 452/4885MGAM 629/4885SI 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.